Desiderio Pina
About Desiderio Pina
Desiderio Pina is a Staff Psychiatrist at Talkiatry with extensive experience in healthcare management and consulting, and a background in psychiatry and public health.
Current Role at Talkiatry
Desiderio Pina has been serving as a Staff Psychiatrist at Talkiatry since 2022. Based in Ohio, United States, he applies his expertise in psychiatry to deliver patient care in a mental health setting.
Consulting Role at Quantum Science Management Group
Desiderio Pina is currently a Senior Healthcare Management Consultant/Scientific Consultant at Quantum Science Management Group. He has been with the organization, formerly known as Quantum Medical Management Partners, since 2011. In this role, he focuses on mergers and acquisitions across multiple locations, including New York, New Jersey, Ohio, and Florida.
Educational Background in Psychiatry and Public Health
Desiderio Pina holds a General Psychiatry specialization and served as Chief Resident at the Icahn School of Medicine at Mount Sinai from 1998 to 2002. He also completed an MPH in Health Policy & Healthcare Management at Columbia University Mailman School of Public Health from 1993 to 1995. His medical degree (MD) was earned from Universidad Iberoamericana, complemented by a Premedical certification from Universidad Nacional Pedro Henríquez Ureña.
Previous Positions in Healthcare
Desiderio Pina has held several key positions in various healthcare organizations. He served as Chief Operating Officer and Chief Medical Officer at Vanguard Eldercare Medical Group in 2019. He was a Consulting Physician at St Joseph's Medical Center, Dupont Hospital, and Lutheran Hospital in Ft Wayne, Indiana, from 2011 to 2013. Additionally, he held a consulting role at the State of Indiana's Department of Family & Social Services during the same period.
Teaching Roles and Research
Desiderio Pina has taught medical and nursing students as an Associate Professor at institutions such as Wright-State SOM, University of Rochester SOM, IU SOM, and Notre Dame University. His research has focused on the mechanisms of neurodegenerative disorders in murine models and participation in clinical pharmaceutical trials. He also served as a visiting fellow at Columbia University's Brain Stimulation and Neuromodulation Center.